Skip to main content
RSC Advances logoLink to RSC Advances
. 2023 Jan 12;13(4):2220–2224. doi: 10.1039/d2ra07872d

Synthesis of 2-iminothiazolidin-4-ones via copper-catalyzed [2 + 1 + 2] tandem annulation

Mingming Zhao a,b, Yiming Guo a,b, Qi Wang a,b, Lanqi Liu a,b, Shujie Zhang a,b, Wei Guo c,, Lin-Ping Wu a,b,, Fayang G Qiu a,b,
PMCID: PMC9834997  PMID: 36741140

Abstract

In this paper, an efficient synthesis of 2-iminothiazolidin-4-ones through a copper-catalyzed tandem annulation reaction of alkyl amines, isothiocyanates and diazo acetates is presented. Notable advantages of this [2 + 1 + 2] cyclization methodology include readily accessible starting materials, simple operation, mild reaction conditions, high yields, step-economy and diverse functional group tolerance. In addition, the reaction is applicable to the gram scale synthesis and the preparation of bioactive molecules.


In this paper, an efficient synthesis of 2-iminothiazolidin-4-ones through a copper-catalyzed tandem annulation reaction of alkyl amines, isothiocyanates and diazo acetates is presented.graphic file with name d2ra07872d-ga.jpg

Introduction

The thiazolidine skeleton, a privileged heterocyclic motif, is ubiquitous in various natural compounds, drug candidates, and pharmacologically active molecules. Specifically, 2-iminothiazolidin-4-one derivatives have attracted much attention due to their broad biological activities1 and have thus been developed as sphingosine-1-phosphate receptor agonists,2 carbonic anhydrase IX inhibitors,3 selective glycogen synthase kinas-3β inhibitors,4 cell division cycle dual phosphatases inhibitors,5 entamoeba histolytica inhibitors,6 and human carbonic anhydrase IX inhibitors.7 Owing to their pharmaceutical importance, some powerful synthetic methodologies have been developed to access 2-iminothiazolidin-4-ones.8 In addition, the one-pot three-component cyclization has been successfully explored for the acquisition of 2-iminothiazolidin-4-ones via amines, isothiocycanates, with chloroacetic acid9 (Scheme 1a)/α-bromoesters10 (Scheme 1b)/alkyl acetylenedicarboxylates11 (Scheme 1c).

Scheme 1. One-pot three-component cyclization of 2-iminothiazolidin-4-ones.

Scheme 1

Despite the great progress, the reported methods suffer from several drawbacks such as high temperature, microwave-irradiation, or difficult to scale-up (visible-light-promoted, Scheme 1b and c). Therefore, there is an urgent need to develop concise and scalable methods for the formation of 2-iminothiazolidin-4-ones under mild reaction conditions.

Diazocarbonyl compounds are a class of versatile and easily accessible building blocks containing two functional groups, thereby affording rich chemistry under different reaction conditions.12 For instance, various cyclopropanations, C–H alkylation, C–X insertion, the Wolff rearrangement, and dipolar cycloaddition reactions have been established.13 In the past few years, the transition-metal-catalyzed diazocarbonyl compounds have been applied to the assembly of N-heterocycles via carbene transfer reactions and such reactions have emerged as a powerful tool in synthetic organic chemistry.14 Here we designed a novel three-component tandem strategy to prepare the 2-iminothiazolidin-4-ones via the copper-catalyzed [2 + 1 + 2] cyclization of alkyl amines, isothiocyanates, and diazo esters (Scheme 1d).

Results and discussion

Our investigations were started with the reaction of phenylmethanamine 1a, phenyl isothiocyanate 2a, and ethyl 2-diazoacetate 3a in CH3CN at room temperature (25 °C) (Table 1). As shown in Table 1, a brief screening of the copper catalysts and iodine reagents suggested that CuI was the best choice (entries 1–12). In this case, 2-iminothiazolidin-4-one (4a) was obtained in 78% yield (entry 5). As expected, no target product was found in the absence of copper catalyst (entry 13). Subsequently, the amount of CuI (Tables S1), the molar ratio of reactants (Tables S2), reaction time (Tables S3) and reaction temperature (Tables S4) were optimized. However, the yield of 4a was not improved (see the ESI Tables S1–S4 and Table 1, entry 6). For example, the yield was decreased to 51% when the reaction was carried out in CH3CN for 6 h (entry 6). Then, the effect of solvents was also investigated (entries 14–19). It was found that the mixture of CH3CN with THF (v/v = 1 : 1) was a more efficient than other solvent systems, affording 4a in 85% yield (entry 19). In addition, when the reaction was performed under N2 or O2 atmosphere, the transformations proceeded without much difference (entries 20–21), illustrating that the effect of oxygen was insignificant.

Screening of reaction conditionsa.

graphic file with name d2ra07872d-u1.jpg
Entry Catalyst Solvent Time (h) Yieldb (%)
1 CuCl2 CH3CN 12 38
2 CuBr2 CH3CN 12 48
3 CuCl CH3CN 12 41
4 CuBr CH3CN 12 51
5 CuI CH3CN 12 78
6 CuI CH3CN 6 51
7 Cu(OAc)2 CH3CN 12 0
8 Cu(OTf)2 CH3CN 12 31
9 Cu(TFA)2 CH3CN 12 65
10 NBS CH3CN 12 22
11 NIS CH3CN 12 42
12 I2 CH3CN 12 49
13 CH3CN 12 0
14 CuI DMF 12 53
15 CuI Acetone 12 68
16 CuI EtOH 12 48
17 CuI MeNO2 12 56
18 CuI THF 12 82
19 CuI CH3CN/THF (1 : 1) 12 85
20c CuI CH3CN/THF (1 : 1) 12 81
21d CuI CH3CN/THF (1 : 1) 12 78
a

Reaction conditions: 1a (0.222 mmol), 2a (0.185 mmol), 3a (0.278 mmol) and catalyst (0.4 equiv.) in solvent (2 mL), open to air at room temperature (25 °C).

b

Isolated yield.

c

Reaction under N2 atmosphere.

d

Reaction under O2 atmosphere.

With the optimal reaction conditions in hand, the substrate scope of this transformation was examined. As shown in Scheme 2, the scope of alkyl amines 1 was illustrated and the reaction was performed on the open air conditions at room temperature (25 °C). In general, the results revealed that benzylamines 1b–1o bearing either an electron-donating group (CH3, OCH3, and OH) or an electron-withdrawing group (Cl, Br, CF3, and CN) on the para-/meta-/ortho-position of the aromatic ring reacted with phenyl isothiocyanate 2a and ethyl 2-diazoacetate 3a smoothly to furnish products 4b–4o in good to excellent yields. Moreover, disubstituted and trisubstituted benzylamines were able to undergo this transformation to afford the desired products 4p–4r in moderate to good isolated yields. Further, naphthalen-1-ylmethanamine, thiophen-2-ylmethanamine, furan-2-ylmethanamine, and pyridin-4-ylmethanamine were applicable to this reaction system providing 4s–4v in moderate yields. When cyclohexylmethanamine and aliphatic amines were employed as competent partners with 2a and 3a, the corresponding products 4w–4za were obtained in good yields. To our delight, the use of 2-(thiophen-2-yl)ethan-1-amine, 2-phenylethan-1-amine, and 3-phenylpropan-1-amine also generated the desired 2-iminothiazolidin-4-ones 4zb–4ze in 59–92% yields. Notably, tryptamine afforded product 4zf in 77% yield. However, aniline failed to give the desired product, which might be due to the conjugation effect between the aromatic ring and the nitrogen atom.

Scheme 2. Scope of RCH2NH2a,b. aReaction conditions: 1 (0.222 mmol), 2a (0.185 mmol), 3a (0.278 mmol) and CuI (0.4 equiv.) in CH3CN/THF (1 : 1) (2 mL), open to air at room temperature (25 °C). bYields of isolated products.

Scheme 2

The scope of isothiocyanates under similar conditions was then investigated, and the results are summarized in Scheme 3. As expected, isothiocyanatobenzenes containing –Cl, –Br, –CF3, –OCH3, –CN groups at the para-, meta-, or ortho-position reacted well with phenylmethanamine 1a and ethyl 2-diazoacetate 3a, producing the desired cyclization products 5a–5h in moderate to excellent yields. Furthermore, disubstituted and trisubstituted isothiocyanatobenzenes provided the desired products 5i–5l as well. For 1-napthyl isothiocyanate, the target product 5m was formed in 77% yield, whereas (isothiocyanatomethyl)benzene gave the corresponding product 5n in 70% yield. In addition, aliphatic isothiocyanates were tried. To our delight, isothiocyanatomethane demonstrated comparable reactivity and provided the desired product 5o in 70% yield. Notably, the CuI catalyzed [2 + 1 + 2] tandem annulation of 1a, o-ethyl carbonisothiocyanatidate 2p, and ethyl 2-diazoacetate 3a at room temperature (25 °C) afforded the 2-iminothiazolidin-4-one 5p in 42% yield. The geometry of the imine double bond at 5p was determined via X-ray crystallographic analysis (see the ESI for details). Further, other substituted diazo compounds were screened under the standardized protocol. However, ethyl 2-diazo-3-oxo-3-phenylpropanoate, ethyl 2-diazo-3-oxobutanoate, or ethyl 2-diazo-2-phenylacetate couldn't be transformed into the target product because of a steric hindrance effect.

Scheme 3. Scope of isothiocyanate compoundsa,b. aReaction conditions: 1a (0.222 mmol), 2 (0.185 mmol), 3a (0.278 mmol) and CuI (0.4 equiv.) in CH3CN/THF (1 : 1) (2 mL), open to air at room temperature (25 °C). bYields of isolated products.

Scheme 3

As shown in Scheme 4, the present method can be performed in gram scale. In addition, this tandem annulation was used to furnish bioactive molecules (Scheme 5). For instance, the reaction of 1v, phenyl isothiocyanate 2a, ethyl 2-diazoacetate 3a, and 4-nitrobenzalde 6 led to 7, a human carbonic anhydrase IX inhibitor,7 in 40% yield via a one-pot annulation (Scheme 5a). Similarly, an entamoeba histolytica inhibitor68 was obtained in 61% yield (Scheme 5b).

Scheme 4. Gram scale.

Scheme 4

Scheme 5. The synthesis of 2-iminothiazolidin-4-one derivatives of bioactive moleculesa. aReaction conditions: 1 (0.222 mmol), 2a (0.185 mmol), 3a (0.278 mmol) and CuI (0.4 equiv.) in CH3CN/THF (1 : 1) (2 mL), open to air at room temperature (25 °C). Isolated yields.

Scheme 5

To gain insight into the mechanism of this reaction, we carried out some control experiments (Scheme 6). Addition of 2,2,6,6-tetramethylpiperidine-N-oxyl (TEMPO), 2,6-di-tert-butyl-4-methylphenol (BHT), or 1,1-diphenylethylene (DPE), showed no significant effects on the yield of the desired product 4a (eqn (1)–(3)), indicating that a radical pathway is unlikely in this reaction. Furthermore, the reaction of 1-benzyl-3-phenylthiourea 9 (ref. 10, 11 and 15) with ethyl 2-diazoacetate 3a carried out under the standard conditions provided 4a in 76% isolated yield, implying that 9 might be a reasonable intermediate in this transformation (eqn (4)). However, when 1-benzyl-3-phenylthiourea 9 was used as the substrate in the absence of CuI, no desired product 4a was detected, suggesting that CuI is essential to the reaction (eqn (5)).

Scheme 6. Mechanistic studies.

Scheme 6

According to these experimental results, a plausible reaction mechanism for the copper-catalyzed tandem annulation reaction is suggested in Scheme 7. First, the reaction of alkyl amine (1) and isothiocyanate (2) gives intermediate A.10,11,15 Next, the intermediate B is obtained from Avia isomerization.10,16 Then the coordination of 3a to the catalyst (CuI) affords the active Cu(i) carbene intermediate C through the extrusion of one N2 molecule.17 Subsequently, nucleophilic attack of intermediate B on Cu(i) carbene intermediate C forms intermediate D, which further generates intermediate E through 1,3-Cu shift. Intermediate E is protonated to produce intermediate G with concomitant regeneration of CuI catalyst. Finally, G undergoes an intramolecular ammonolysis/cyclization to yield the desired product 4. In the meantime, it is also possible that CuI first reacts with intermediate B to provide intermediate F, followed by metal carbene generation via its reaction with 3a to give D.

Scheme 7. Proposed reaction mechanism.

Scheme 7

Conclusions

In conclusion, we have explored a novel copper-catalyzed tandem annulation reaction of alkyl amines, isothiocyanates, and diazo esters for the construction of 2-iminothiazolidin-4-ones under mild reaction conditions. This transformation represents a copper-catalyzed C–S/C–N bond formation strategy in a one-pot protocol without the requirement of any external bases, ligands, or oxidants. It shows wide functional group tolerance, high yields, and high step economy. In addition, this protocol is applicable to the gram scale synthesis and the preparation of bioactive molecules with such structural motif, which may facilitate the research of such bioactive molecules in medicinal chemistry.

Conflicts of interest

There are no conflicts to declare.

Supplementary Material

RA-013-D2RA07872D-s001
RA-013-D2RA07872D-s002

Acknowledgments

We are grateful to the National Natural Science Foundation of China (NNSFC) (Grant No. 21971243) for financial support.

Electronic supplementary information (ESI) available. CCDC 2190019. For ESI and crystallographic data in CIF or other electronic format see DOI: https://doi.org/10.1039/d2ra07872d

References

  1. Vicini P. Geronikaki A. Anastasia K. Incerti M. Zani F. Bioorg. Med. Chem. 2006;14:3859–3864. doi: 10.1016/j.bmc.2006.01.043. [DOI] [PubMed] [Google Scholar]
  2. Bolli M. H. Abele S. Binkert C. Bravo R. Buchmann S. Bur D. Gatfield J. Hess P. Kohl C. Mangold C. Mathys B. Menyhart K. Müller C. Nayler O. Scherz M. Schmidt G. Sippel V. Steiner B. Strasser D. Treiber A. Weller T. J. Med. Chem. 2010;53:4198–4211. doi: 10.1021/jm100181s. [DOI] [PubMed] [Google Scholar]
  3. Bianco G. Meleddu R. Distinto S. Cottiglia F. Gaspari M. Melis C. Corona A. Angius R. Angeli A. Taverna D. Alcaro S. Leitans J. Kazaks A. Tars K. Supuran C. T. Maccioni E. ACS Med. Chem. Lett. 2017;8:792–796. doi: 10.1021/acsmedchemlett.7b00205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Arfeen M. Bhagat S. Patel R. Prasad S. Roy I. Chakraborti A. K. Bharatam P. V. Eur. J. Med. Chem. 2016;121:727–736. doi: 10.1016/j.ejmech.2016.04.075. [DOI] [PubMed] [Google Scholar]
  5. Huber-Villaume S. Revelant G. Sibille E. Philippot S. Morabito A. Dunand S. Chaimbault P. Bagrel D. Kirsch G. Hesse S. Schohn H. Bioorg. Med. Chem. 2016;24:2920–2928. doi: 10.1016/j.bmc.2016.04.063. [DOI] [PubMed] [Google Scholar]
  6. Mushtaque M. Avecilla F. Azam A. Eur. J. Med. Chem. 2012;55:439–448. doi: 10.1016/j.ejmech.2012.06.052. [DOI] [PubMed] [Google Scholar]
  7. Ansari M. F. Idrees D. Hassan M. I. Ahmad K. Avecilla F. Azam A. Eur. J. Med. Chem. 2018;144:544–556. doi: 10.1016/j.ejmech.2017.12.049. [DOI] [PubMed] [Google Scholar]
  8. (a) Kumar D. Sonawane M. Pujala B. Jain V. K. Bhagat S. Chakraborti A. K. Green Chem. 2013;15:2872–2884. [Google Scholar]; (b) Kasmi-Mir S. Djafri A. Paquin L. Hamelin J. Rahmouni M. Molecules. 2006;11:597–602. doi: 10.3390/11080597. [DOI] [PMC free article] [PubMed] [Google Scholar]; (c) Saeed A. Abbas N. Flörke U. J. Braz. Chem. Soc. 2007;18:559–565. [Google Scholar]; (d) Laurent D. R. St. Gao Q. Wu D. Serrano-Wu M. H. Tetrahedron Lett. 2004;45:1907–1910. [Google Scholar]
  9. Sathishkumar M. Nagarajan S. Shanmugavelan P. Dinesh M. Ponnuswamy A. Beilstein J. Org. Chem. 2013;9:689–697. doi: 10.3762/bjoc.9.78. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Guo W. Zhao M. Tan W. Zheng L. Tao K. Liu L. Wang X. Chen D. Fan X. J. Org. Chem. 2018;83:1402–1413. doi: 10.1021/acs.joc.7b02940. [DOI] [PubMed] [Google Scholar]
  11. Guo W. Tao K. Zheng L. Zhao M. Tan W. Cai L. Xie Z. Chen D. Fan X. J. Org. Chem. 2019;84:6448–6458. doi: 10.1021/acs.joc.9b00305. [DOI] [PubMed] [Google Scholar]
  12. (a) Regitz M. and Maas G., Diazo compounds: properties and synthesis, Academic Press, Orlando, FL, USA, 1986, p. 608 [Google Scholar]; (b) Doyle M. P., McKervey M. A. and Ye T., Modern catalytic methods for organic synthesis with diazo compounds: from cyclopropanes to ylides, J Wiley & Sons, New York, USA, 1998, p. 652 [Google Scholar]; (c) Burtoloso A. C. B. Momo P. B. Novais G. L. An. Acad. Bras. Cienc. 2018;90:859–893. doi: 10.1590/0001-3765201820170768. [DOI] [PubMed] [Google Scholar]
  13. (a) Lebel H. Marcoux J.-F. Molinaro C. Charette A. B. Chem. Rev. 2003;103:977–1050. doi: 10.1021/cr010007e. [DOI] [PubMed] [Google Scholar]; (b) Brackmann F. de Meijere A. Chem. Rev. 2007;107:4493–4497. doi: 10.1021/cr078376j. [DOI] [PubMed] [Google Scholar]; (c) Ford A. Miel H. Ring A. Slattery C. N. Maguire A. R. McKervey M. A. Chem. Rev. 2015;115:9981–10080. doi: 10.1021/acs.chemrev.5b00121. [DOI] [PubMed] [Google Scholar]; (d) Gillingham D. Fei N. Chem. Soc. Rev. 2013;42:4918–4931. doi: 10.1039/c3cs35496b. [DOI] [PubMed] [Google Scholar]; (e) Zhang Z. Wang J. Tetrahedron. 2008;64:6577–6605. [Google Scholar]; (f) Doyle M. P. Duffy R. Ratnikov M. Zhou L. Chem. Rev. 2010;110:704–724. doi: 10.1021/cr900239n. [DOI] [PubMed] [Google Scholar]
  14. (a) Li Y.-P. Li Z.-Q. Zhu S.-F. Tetrahedron Lett. 2018;59:2307–2316. [Google Scholar]; (b) Burtoloso A. C. B. Dias R. M. P. Bernardim B. Acc. Chem. Res. 2015;48:921–934. doi: 10.1021/ar500433t. [DOI] [PubMed] [Google Scholar]
  15. (a) de Sequeira Aguiar L. C. Viana G. M. dos Santos Romualdo M. V. Costa M. V. Bonato B. S. Lett. Org. Chem. 2011;8:540–544. [Google Scholar]; (b) Bade T. Vedula R. R. J. Heterocycl. Chem. 2015;52:1883–1886. [Google Scholar]; (c) Tumula N. Jatangi N. Palakodety R. K. Balasubramanian S. Nakka M. J. Org. Chem. 2017;82:5310–5316. doi: 10.1021/acs.joc.7b00646. [DOI] [PubMed] [Google Scholar]; (d) Chu J.-J. Hu B.-L. Liao Z.-Y. Zhang X.-G. J. Org. Chem. 2016;81:8647–8652. doi: 10.1021/acs.joc.6b01668. [DOI] [PubMed] [Google Scholar]; (e) Wangngae S. Pattarawarapan M. Phakhodee W. J. Org. Chem. 2017;82:10331–10340. doi: 10.1021/acs.joc.7b01794. [DOI] [PubMed] [Google Scholar]
  16. Guo W. Zhao M. Tan W. Zheng L. Tao K. Chen L. Wang M. Chen D. Fan X. Asian J. Org. Chem. 2018;7:1893–1897. [Google Scholar]
  17. (a) Rivilla I. Sameera W. M. C. Alvarez E. Díaz-Requejo M. M. Maseras F. Pérez P. J. Dalton Trans. 2013;42:4132–4138. doi: 10.1039/c2dt32439c. [DOI] [PubMed] [Google Scholar]; (b) Li J. Tang M. Zang L. Zhang X. Zhang Z. Ackermann L. Org. Lett. 2016;18:2742–2745. doi: 10.1021/acs.orglett.6b01199. [DOI] [PubMed] [Google Scholar]; (c) Chen Z. Hu X. Huang J. Zeng W. Org. Lett. 2018;20:3980–3983. doi: 10.1021/acs.orglett.8b01541. [DOI] [PubMed] [Google Scholar]; (d) Ioannou M. Porter M. J. Saez F. Chem. Commun. 2002:346–347. doi: 10.1039/b110754b. [DOI] [PubMed] [Google Scholar]; (e) Su J. Li Q. Shao Y. Sun J. Org. Lett. 2022;24:1637–1641. doi: 10.1021/acs.orglett.2c00151. [DOI] [PubMed] [Google Scholar]; (f) Yu C. Xu Y. Zhang X. Fan X. J. Org. Chem. 2022;87:7392–7404. doi: 10.1021/acs.joc.2c00628. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

RA-013-D2RA07872D-s001
RA-013-D2RA07872D-s002

Articles from RSC Advances are provided here courtesy of Royal Society of Chemistry

RESOURCES